Click on one of these terms to refine your search
1 to 10 of 66 literature results
Hyaluronic acid (HA) promotes tumor metastasis and is an accurate diagnostic marker for bladder cancer. HA is synthesized by HA synthases HAS1, HAS2, …
Authors: Roozbeh Golshani, Luis Lopez, Veronica Estrella, Mario Kramer, Naoko Iida, Vinata B Lokeshwar
Source: Cancer research. 2008 Jan 15
View Full TextPlants have evolved protective mechanisms to ensure their survival when threatened by adverse environmental conditions during their transition to auto…
Authors: Luis Lopez-Molina, Sébastien Mongrand, Natsuko Kinoshita, Nam-Hai Chua
Source: Genes & development. 2003 Feb 1
View Free Full TextMammalian circadian rhythms are generated by a feedback loop in which BMAL1 and CLOCK, players of the positive limb, activate transcription of the cry…
Authors: Nicolas Preitner, Francesca Damiola, Luis Lopez-Molina, Joszef Zakany, Denis Duboule, Urs Albrecht, Ueli Schibler
Source: Cell. 2002 Jul 26
View Full TextTumor cells express HYAL1 hyaluronidase, which degrades hyaluronic acid. HYAL1 expression in bladder cancer cells promotes tumor growth, invasion, and…
Authors: Vinata B Lokeshwar, Veronica Estrella, Luis Lopez, Mario Kramer, Pablo Gomez, Mark S Soloway, Bal L Lokeshwar
Source: Cancer research. 2006 Dec 1
View Full TextAIMS: International guidelines are frequently not implemented in the elderly population with heart failure (HF). This study determined the management …
Authors: Michel Komajda, Olivier Hanon, Matthias Hochadel, Jose Luis Lopez-Sendon, Ferenc Follath, Piotr Ponikowski, Veli-Pekka Harjola, Helmut Drexler, Kenneth Dickstein, Luigi Tavazzi,…
Source: European heart journal. 2009 Feb
View Full TextVoltage-gated Na(+) channel (VGSC) beta1 and beta2 subunits are multifunctional, serving as both channel modulators and cell adhesion molecules (CAMs)…
Authors: Dyke P McEwen, Chunling Chen, Laurence S Meadows, Luis Lopez-Santiago, Lori L Isom
Source: Neuroscience letters. 2009 Oct 25
View Full TextAIMS: The objective of the EuroHeart Failure Survey II (EHFS II) was to assess patient characteristics, aetiology, treatment, and outcome of acute hea…
Authors: Markku S Nieminen, Dirk Brutsaert, Kenneth Dickstein, Helmut Drexler, Ferenc Follath, Veli-Pekka Harjola, Matthias Hochadel, Michel Komajda, Johan Lassus, Jose Luis Lopez-Sendon,…
Source: European heart journal. 2006 Nov
View Full TextOBJECTIVE: To characterise the population pharmacokinetics of trabectedin (ET-743, Yondelis(R)) in cancer patients. METHODS: A total of 603 patients (…
Authors: Juan Jose Perez-Ruixo, Peter Zannikos, Sarapee Hirankarn, Kim Stuyckens, Elizabeth A Ludwig, Arturo Soto-Matos, Luis Lopez-Lazaro, Joel S Owen
Source: Clinical pharmacokinetics. 2007
View Full TextAuthors: Raul Moreno, David Dobarro, Esteban López de Sá, Mario Prieto, Carmen Morales, Luis Calvo Orbe, Isidro Moreno-Gomez, David Filgueiras, Angel Sanchez-Recalde, Guillermo Galeote,…
Source: Circulation. 2009 Aug 4
View Full TextA precise description of clinical features at presentation and analysis of clinical and biologic prognostic factors in splenic marginal zone lymphoma …
Authors: Jose I Chacón, Manuela Mollejo, Enriqueta Muñoz, Patricia Algara, Marisol Mateo, Luis Lopez, Jesús Andrade, Iciar García Carbonero, Beatriz Martínez, Miguel A Piris,…
Source: Blood. 2002 Sep 1
View Full Text